News
3d
Amazon S3 on MSNDiabetes, SGLT2's and Related Cardiovascular Outcome TrialsLori Berard, RN, DCE, Diabetes Educator, Nurse Consultant, reviews SGLT2's mechanism of action and benefits and discusses how ...
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...
Feline diabetes mellitus (DM) is currently understood to have strong similarities to human type 2 diabetes. Veterinarians have traditionally relied upon insulin therapy to treat feline DM. However, ...
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.
Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM): As far as side effects, the most common are gastrointestinal. And right now there ...
Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...
The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for ...
4don MSN
Patients with low skeletal muscle mass are at a higher risk of falling. Certain diabetes medications, particularly SGLT2 ...
SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.
1d
Verywell Health on MSN9 Medication Options for Managing Kidney DiseaseExplore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results